Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.454 USD | +8.87% | -2.16% | -18.93% |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 60.66M |
---|---|---|---|---|---|
Net income 2021 | -23M | Net income 2022 | -15M | EV / Sales 2021 | - |
Net cash position 2021 | 42.19M | Net cash position 2022 | 17.76M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.01
x | P/E ratio 2022 |
-3.95
x | Employees | 9 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.71% |
Latest transcript on Tiziana Life Sciences Ltd
1 day | +8.87% | ||
1 week | -2.16% | ||
Current month | -5.53% | ||
1 month | -8.32% | ||
3 months | -20.20% | ||
6 months | -32.32% | ||
Current year | -18.93% |
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.454 | +8.87% | 33,105 |
24-03-27 | 0.417 | -2.11% | 64,900 |
24-03-26 | 0.426 | -5.96% | 73,939 |
24-03-25 | 0.453 | -2.58% | 79,854 |
24-03-22 | 0.465 | +0.22% | 19,443 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.93% | 41.83M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |